Cytosolic and mitochondrial translation elongation are coordinated through the molecular chaperone TRAP1 for the synthesis and import of mitochondrial proteins.


Journal

Genome research
ISSN: 1549-5469
Titre abrégé: Genome Res
Pays: United States
ID NLM: 9518021

Informations de publication

Date de publication:
08 2023
Historique:
received: 31 01 2023
accepted: 19 07 2023
medline: 2 10 2023
pubmed: 25 7 2023
entrez: 24 7 2023
Statut: ppublish

Résumé

A complex interplay between mRNA translation and cellular respiration has been recently unveiled, but its regulation in humans is poorly characterized in either health or disease. Cancer cells radically reshape both biosynthetic and bioenergetic pathways to sustain their aberrant growth rates. In this regard, we have shown that the molecular chaperone TRAP1 not only regulates the activity of respiratory complexes, behaving alternatively as an oncogene or a tumor suppressor, but also plays a concomitant moonlighting function in mRNA translation regulation. Herein, we identify the molecular mechanisms involved, showing that TRAP1 (1) binds both mitochondrial and cytosolic ribosomes, as well as translation elongation factors; (2) slows down translation elongation rate; and (3) favors localized translation in the proximity of mitochondria. We also provide evidence that TRAP1 is coexpressed in human tissues with the mitochondrial translational machinery, which is responsible for the synthesis of respiratory complex proteins. Altogether, our results show an unprecedented level of complexity in the regulation of cancer cell metabolism, strongly suggesting the existence of a tight feedback loop between protein synthesis and energy metabolism, based on the demonstration that a single molecular chaperone plays a role in both mitochondrial and cytosolic translation, as well as in mitochondrial respiration.

Identifiants

pubmed: 37487647
pii: gr.277755.123
doi: 10.1101/gr.277755.123
pmc: PMC10547376
doi:

Substances chimiques

HSP90 Heat-Shock Proteins 0
Mitochondrial Proteins 0
Molecular Chaperones 0
TRAP1 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1242-1257

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM080376
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

© 2023 Avolio et al.; Published by Cold Spring Harbor Laboratory Press.

Références

Cell. 2007 Oct 19;131(2):257-70
pubmed: 17956728
Genes (Basel). 2018 Apr 05;9(4):
pubmed: 29621137
J Transl Genet Genom. 2020;4:71-80
pubmed: 33426504
Trends Genet. 2018 Sep;34(9):682-692
pubmed: 29945721
Antioxid Redox Signal. 2015 Apr 20;22(12):995-1019
pubmed: 25557408
Mol Cell Biol. 2010 Jan;30(1):284-94
pubmed: 19858288
Cell Death Differ. 2012 Apr;19(4):592-604
pubmed: 21979464
Stress. 2007 Nov;10(4):342-50
pubmed: 17853063
Int J Biochem Cell Biol. 2014 Mar;48:77-84
pubmed: 24412566
Cancer Res. 2010 Aug 15;70(16):6577-86
pubmed: 20647321
Nat Rev Cancer. 2012 Oct;12(10):685-98
pubmed: 23001348
Sci Rep. 2017 Jun 16;7(1):3731
pubmed: 28623368
Biochim Biophys Acta. 2013 May;1827(5):612-26
pubmed: 23274250
Biochim Biophys Acta. 2013 Feb;1833(2):260-73
pubmed: 23457718
Genes Dev. 2018 Oct 1;32(19-20):1285-1296
pubmed: 30275044
PLoS Comput Biol. 2017 Jun 9;13(6):e1005592
pubmed: 28598992
J Cell Sci. 2018 May 31;131(10):
pubmed: 29700204
Mol Cell. 2016 Mar 3;61(5):667-676
pubmed: 26942671
Cancer Cell Int. 2022 Dec 12;22(1):402
pubmed: 36510251
ACS Chem Biol. 2014 Oct 17;9(10):2421-31
pubmed: 25126896
Trends Cell Biol. 2014 Aug;24(8):455-63
pubmed: 24731398
Expert Opin Ther Targets. 2017 Aug;21(8):805-815
pubmed: 28664757
J Biol Chem. 2000 Feb 4;275(5):3305-12
pubmed: 10652318
Trends Biochem Sci. 2013 Dec;38(12):585-91
pubmed: 24126073
Cell Death Differ. 2022 Dec;29(12):2335-2346
pubmed: 35614131
Cell. 2006 Jan 13;124(1):75-88
pubmed: 16413483
Mitochondrion. 2020 Mar;51:1-6
pubmed: 31821898
BMC Biol. 2020 Jan 27;18(1):10
pubmed: 31987035
Cell Cycle. 2011 Jan 15;10(2):229-40
pubmed: 21220943
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):E1604-12
pubmed: 23564345
Nat Commun. 2013;4:2139
pubmed: 23842546
Nucleic Acids Res. 2019 Jan 8;47(D1):D55-D62
pubmed: 30462320
Elife. 2020 Aug 03;9:
pubmed: 32744497
Curr Protoc Neurosci. 2013 Apr;Chapter 5:Unit5.22
pubmed: 23559306
J Cell Biol. 2014 Oct 27;207(2):213-23
pubmed: 25349259
Nat Protoc. 2009;4(11):1582-90
pubmed: 19816421
Int J Oncol. 2014 Sep;45(3):969-77
pubmed: 24990602
Curr Protoc. 2021 Mar;1(3):e90
pubmed: 33780170
J Biol Chem. 1995 Feb 24;270(8):3574-81
pubmed: 7876093
Nucleic Acids Res. 2010 Jan;38(Database issue):D131-6
pubmed: 19917642
Front Oncol. 2016 May 25;6:128
pubmed: 27252909
Nature. 2016 May 11;533(7604):499-503
pubmed: 27225121
EMBO Rep. 2021 Apr 7;22(4):e51635
pubmed: 33586863
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Mol Oncol. 2020 Dec;14(12):3030-3047
pubmed: 33025742
Mol Ther. 2007 May;15(5):938-45
pubmed: 17311008
Cell Metab. 2013 Jun 4;17(6):988-999
pubmed: 23747254
Nucleic Acids Res. 2018 Dec 14;46(22):12067-12086
pubmed: 30260431
Int J Oncol. 2014 Feb;44(2):573-82
pubmed: 24297638
Methods Mol Biol. 2021;2192:211-226
pubmed: 33230776
Cell. 2012 Jun 8;149(6):1393-406
pubmed: 22658674
Sci Signal. 2013 Apr 16;6(271):ra24
pubmed: 23592839
Nucleic Acids Res. 2012 Jan;40(2):541-52
pubmed: 21917851
Elife. 2020 Aug 07;9:
pubmed: 32762840
Mol Cell Biol. 1996 Sep;16(9):4691-9
pubmed: 8756626
Mol Oncol. 2014 Dec;8(8):1482-94
pubmed: 24962791
Cells. 2020 Mar 30;9(4):
pubmed: 32235572
Cell Death Dis. 2013 Oct 10;4:e851
pubmed: 24113185
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Sci Rep. 2016 Jun 24;6:28186
pubmed: 27339025
Oncotarget. 2017 Mar 28;8(13):21229-21240
pubmed: 28177905

Auteurs

Rosario Avolio (R)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Ilenia Agliarulo (I)

Institute of Experimental Endocrinology and Oncology "G. Salvatore"-IEOS, National Research Council of Italy (CNR), Naples 80131, Italy.

Daniela Criscuolo (D)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Daniela Sarnataro (D)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Margherita Auriemma (M)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Sabrina De Lella (S)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Sara Pennacchio (S)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy.

Giovanni Calice (G)

Laboratory of Preclinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, Rionero in Vulture 85028, Italy.

Martin Y Ng (MY)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6323, USA.

Carlotta Giorgi (C)

Department of Medical Sciences, University of Ferrara, Ferrara 44121, Italy.

Paolo Pinton (P)

Department of Medical Sciences, University of Ferrara, Ferrara 44121, Italy.

Barry S Cooperman (BS)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6323, USA.

Matteo Landriscina (M)

Institute of Experimental Endocrinology and Oncology "G. Salvatore"-IEOS, National Research Council of Italy (CNR), Naples 80131, Italy.
Department Medical and Surgical Science, University of Foggia, Foggia 71122, Italy.

Franca Esposito (F)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy; daniloswann.matassa@unina.it franca.esposito@unina.it.

Danilo Swann Matassa (DS)

Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples 80131, Italy; daniloswann.matassa@unina.it franca.esposito@unina.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH